New York Personal Injury Attorneys
Zantac Recall Attorney
On September 13, 2019, the U.S. Food and Drug Administration began investigating the drug Ranitidine (brand name Zantac) after a Citizen Petition was issued by Valisure, an online specialty pharmacy that detected extraordinary levels of NDMA in Ranitidine. Following this discovery, numerous manufacturers have recalled their Zantac and Ranitidine products.
If you or a loved one was a regular user of Zantac and has been diagnosed with a digestive tract cancer, please contact the law offices of Sullivan, Papain, Block, McGrath & Cannavo, P.C. today to discuss your case. You may be eligible for significant compensation for your injuries.
Why Choose Us?
At Sullivan, Papain, Block, McGrath & Cannavo, P.C., our product liability attorneys are dedicated to seeking justice for you and obtaining the maximum possible compensation for your injuries.
- We have over 75 years of combined legal experience representing clients in all types of product liability and defective drug cases.
- We are a full-service law firm that handles all legal matters so that you can focus on healing and recovery.
- We have a reputation for success and results, successfully obtaining more than $2 billion in settlements and verdicts total for our clients.
- We are not intimidated by large companies and corporate legal teams, successfully representing clients in high-profile cases such as the 1993 World Trade Center bombing and 9/11 recovery and rescue workers cases.
- We represent all clients on a contingency fee arrangement. There are no upfront legal costs, and you only pay fees at the conclusion of your case if we secure a settlement or verdict on your behalf.
We are dedicated to holding pharmaceutical companies accountable for any negligent actions that may have caused profound harm to you and your loved ones.
What is Zantac?
Zantac is a popular over-the-counter drug currently manufactured by pharmaceutical company Sanofi. The active drug in Zantac, ranitidine, is an antacid commonly used to treat heartburn and other more serious health conditions such as acid reflux and gastroesophageal reflux disease (GERD).
Why is Zantac Dangerous to Consumers?
In 2019, a third-party pharmacy tested samples of Zantac and found exceedingly high levels of N-nitrosodimethylamine (NDMA) in the drug. NDMA is a carcinogenic chemical that can be extremely potent in high levels of consumption. In fact, scientists and researchers often use NDMA in live animal cancer studies to induce tumors in live mice. While the FDA’s “acceptable” daily intake for NDMA is 96 ng, Valisure’s testing demonstrated the presence of approximately 3,000,000 ng of NDMA in a single ranitidine tablet.
Not only did the recent Zantac testing yield alarming results, but it suggested that the ranitidine molecule itself, can be broken down into NDMA. Although the manufacturers claim that this could only happen if Zantac were exposed to extremely high heat, further testing has found abnormally high trace amounts of NDMA in packaged samples of Zantac – demonstrating the instability of the drug.
The Increasing Scope of the Zantac Recall
On September 23rd, 2019, the FDA announced the first voluntary recall of drugs containing ranitidine. Since then, there have been 14 additional recalls from notable pharmaceutical manufacturers, including:
- Sandoz Inc.
- Apotex Corp.
- Perrigo Company
- Reddy’s (who produces drugs for stores such as Kroger and Walgreens)
- Novitium Pharma
- Lannett Company, Inc.
- Aurobindo & DG Health
- GSMS, Inc.
- Precision Dose Inc.
- Amneal Pharmaceuticals
- Glenmark Pharmaceuticals
- Appco Pharma
- Northwind Pharmaceuticals
The Health Risks Associated With Zantac Use
Those who have consistently consumed Zantac for an extended period of time, are likely at an increased risk for forms of cancer in the digestive tract due to the excessive amounts of NDMA consumption. This includes:
- Bladder cancer
- Stomach cancer
- Kidney cancer
- Liver cancer
- Esophageal cancer
- Colorectal cancer
- Intestinal cancer
- Pancreatic cancer
Who May be Liable for These Cancers?
Pharmaceutical companies have a duty to produce safe drugs and to warn the public of health risks associated with their drugs. Zantac has been manufactured by a number of different pharmaceutical companies, including GlaxoSmithKline, Pfizer, Boehringer Ingelheim, and Sanofi-AS, any of which may be responsible for cancers caused by Zantac, depending on when Zantac was consumed.
We Can Help You Seek Justice Against Zantac Manufacturers
At Sullivan, Papain, Block, McGrath & Cannavo, P.C., we have the resources, experience, and knowledge of product liability cases to help you receive compensation for any serious illnesses contracted as a result of regular Zantac consumption.
- Cases against large corporations such as pharmaceutical companies can be incredibly complex, intimidating, and stressful. Our experience in high-profile cases gives us the confidence to take on big businesses without hesitation.
- Our attorneys understand that lawsuits against large companies can be a long, grueling fight. We can give you peace of mind by handling everything on the legal end, so that you can focus on your health and recovery.
- Defective drug cases usually affect large groups of people. Our attorneys may be able to find others with common experiences, strengthening your case and improving your chances at compensation.
We are committed to securing the maximum possible compensation for your needs, so that you can have a chance at full recovery, and we can hold any accountable parties responsible for their negligent actions.
Contact Us Today
If you or a loved one has contracted a form of cancer due to regular Zantac or ranitidine use, please contact our New York City product liability attorneys today. We are here to help you seek justice for the irresponsible actions of several pharmaceutical companies. Schedule a free confidential consultation with us to see how we can help.